Paul Tudor Jones Vera Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 24,478 shares of VERA stock, worth $906,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,478Holding current value
$906,175% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$160 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$146 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$124 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$110 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$103 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...